Oncternal Therapeutics, Inc.
ONCTDelisted Mar 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001260990
Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Oncternal Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 53 | 52 | −1 |
| Shares | 9.46M | 9.33M | −132.9K (−1.4%) |
| Value | $3.26M | $2.81M | −$458.2K (−14.0%) |
New holders (4)
Institutions that held Oncternal Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pasadena Private Wealth, LLC | 278,750 | $83.6K | 0.03% |
| Two Sigma Securities, LLC | 21,224 | $6.37K | 0.00% |
| Baader Bank INC | 10,149 | $2.71K | 0.00% |
| Qube Research & Technologies Ltd | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Oncternal Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Kennedy Capital Management, Inc. | 587,366 | $202.6K |
| IPG Investment Advisors LLC | 23,691 | $8.17K |
| Fort Point Capital Partners LLC | 20,060 | $6.92K |
| Resources Investment Advisors, LLC. | 11,731 | $4.05K |
| Rhumbline Advisers | 50 | $17 |